# K011916: Super C Hemodialysis/Apheresis Chronic Catheter, Model DC-36 Series, DC-40 Series, DC-45 Series

- Pathway: 510(k) (Traditional)
- Applicant: Horizon Medical Products, Inc.
- Decided: Oct 31, 2001 after 133 days
- Product code: MSD (Catheter, Hemodialysis, Implanted)
- Device class: 2
- Regulation: 21 CFR 876.5540
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K925819 (1994). 4 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K925819: AKCESS0CATH Kit, Akcess Medical Products, Inc. (1994) Summary page 1.
- K981994: Vascath Opti-Flow Long Term Dual Lumen Hemodialysis Catheter, C.R. Bard, Inc. (1998) Summary page 1.
- K010567: Optiflow Catheter #5641190 Catheter Only #5643150 Catheter Kit #5631000 Catheterless Tray-Generic (Combined with Cathetr, C.R. Bard, Inc. (2001) Summary page 1.
- K972207: Medcomp Ash Split-Cath 28CM, Medcomp Ash Split-Cath 32CM, Medcomp (1998) Summary page 1.

## Most influential descendants
- K022905: Lifejet F16 Hemodialysis/Apheresis Chronic Catheter (2002), 0 descendants of its own

## Indications for use
The Super C™ Hemodialysis/Apheresis Chronic Catheter is indicated for use in attaining short and long term vascular access for hemodialysis, hemoperfusion or apheresis therapy via the jugular or subclavian vein. The catheter is intended for implantation dwell time of greater than 30 days.

Source page: https://510kreport.com/device/K011916
Methodology: https://510kreport.com/methodology